GlassScriptPhysician profile
Lauren Milner
NPI 1710205547
$2,020.34
in general payments reported to CMS, 2019-2025
18 companies · $416 in 2025
The $416 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $49.67 · 2021: $222 · 2022: $306 · 2023: $411 · 2024: $285 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $610.35 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $252.88 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $247.53 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.68 | 2020-2022 | |
| Tris Pharma INC | $164.28 | 2021-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $116.11 | 2019-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Supernus Pharmaceuticals, INC. | $115.39 | 2023-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $76.55 | 2019-2023 | Bexsero |
| Collegium Pharmaceutical, INC. | $61.73 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $45.35 | 2019-2025 | |
| Genentech USA, INC. | $32.42 | 2019-2020 | |
| Neos Therapeutics, LP | $30.85 | 2019 | |
| Shire North American Group INC | $28.01 | 2019 | |
| Verrica Pharmaceuticals INC. | $18.40 | 2024 | Ycanth |
| Sanofi-Aventis U.S. LLC | $16.01 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $13.94 | 2024 | Flucelvax |
| Novartis Pharmaceuticals Corporation | $12.80 | 2019 | |
| Aytu Biopharma, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Milner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.